Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Endoscopic sphincterotomy in the early treatment of acute pancreatitis

Article Abstract:

Early diagnosis of gallstones with endoscopic retrograde cholangiopancreatography (ERCP) may improve the outcome of patients with acute pancreatitis. Studies on the early surgical removal of gallstones in these patients have produced mixed results on its effectiveness in lowering the risk of death. Emergency endoscopic surgery following diagnosis with ERCP has been proposed as an alternative to conventional surgery. A recent Hong Kong study did not corroborate a previous British study which found that patients undergoing endoscopic surgery had lower rates of death and complications than patients receiving conventional treatment. The Hong Kong study did find, however, that endoscopic surgery prevented bacterial infections of the biliary tract. ERCP is essential for an accurate early diagnosis of gallstones, but until further studies are conducted, emergency endoscopic surgery may be warranted only for patients whose pancreatic attack is predicted to be severe, who do not respond to conservative treatment or who have a suspected case of acute cholangitis.

Author: Williamson, Robin C.N.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1993
Editorial, Diagnosis, Surgery, Gallstones, Endoscopic surgery

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography

Article Abstract:

Gabexate may prevent pancreatic damage in patients who have endoscopic retrograde cholangiopancreatography (ERCP). ERCP is a procedure used to diagnose pancreatic diseases. Of 418 patients scheduled for an ERCP, 208 received the protease inhibitor gabexate before the procedure and 210 received a placebo. Gabexate significantly reduced pancreatic enzyme levels indicative of pancreatic damage. Only 6% of those who received gabexate developed abdominal pain compared to 14% of the placebo group. Two percent of the gabexate group developed pancreatitis compared to 8% of the placebo group.

Author: Cavallini, Giorgio, Tittobello, Alberto, Frulloni, Luca, Masci, Enzo, Mariani, Alberto, Di Francesco, Vincenzo
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1996
Prevention, Complications and side effects, Protease inhibitors

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: Evaluation, Pancreatitis, Endoscopic retrograde cholangiopancreatography
Similar abstracts:
  • Abstracts: New perspectives for the effective treatment of preterm labor. Randomized comparison of the effects of endocervical and vaginal prostaglandin E2 gel in women with various degrees of cervical ripeness
  • Abstracts: The efficacy of endoscopic sphincterotomy after cholecystectomy in patients with sphincter-of-Oddi dysfunction
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.